Unique concept of MDx, Seegene Random Access System, announced at AACC 2017
Published on: PR Newswire SEOUL, South Korea, July 26, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, is
Seegene enters the U.S. diagnostic market in collaboration with Thermo Fisher Scientific
Published on: PR Newswire SEOUL, South Korea, May 22, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, today
Seegene Unlocks the Door to the Next Level of the Real-time PCR Business
Published on: PR Newswire SYS-CON MEDIA SEOUL, South Korea, April 26, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), the leading developer of multiplex PCR technologies, announced that
Seegene Develops New Normalization Software Technology for Molecular Diagnosis
Published on: PR Newswire NEWS PROVIDED BY Seegene Feb 14, 2017, 08:00 ET EOUL, South Korea, Feb. 14, 2017 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer
Seegene and Hologic Form Worldwide Collaboration to Develop High Multiplex Molecular Diagnostic Assays
Published on: PR Newswire GenomeWeb Seoul, Korea, November 4, 2016 — Seegene Inc. (096530.KQ) today announced it has entered into a worldwide collaboration agreement with Hologic (Nasdaq:
Seegene to Introduce Automated Development of in silico-based Multiplex Real-time PCR Assays
Published on: PR Newswire Pressemitteilung lavanguardia 共同通信PRワイヤー (プレスリリース) HiNet 新聞社群 中华网 ThaiPR.net (ข่าวประชาสัมพันธ์) LeLézard.com foodqualitynews Customized assay design that dramatically reduces development time and cost Looking for potential local strategic partners in molecular